|
|||||
|
|
| Oct-31 | |
| Oct-23 | |
| Oct-20 | |
| Oct-14 | |
| Oct-08 | |
| Oct-03 | |
| Oct-02 | |
| Oct-01 | |
| Sep-29 | |
| Sep-24 | |
| Sep-18 | |
| Sep-12 | |
| Sep-10 | |
| Aug-21 | |
| Aug-11 | |
| Aug-08 | |
| Aug-07 |
Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt
QNTM
GlobeNewswire
|
| Aug-05 | |
| Aug-04 | |
| Jul-31 | |
| Jul-22 | |
| Jul-08 | |
| Jun-27 | |
| Jun-27 | |
| Jun-26 | |
| Jun-17 | |
| Jun-13 | |
| Jun-10 | |
| Jun-03 | |
| May-30 | |
| May-29 | |
| May-28 | |
| May-21 | |
| May-20 | |
| May-19 | |
| May-16 | |
| May-12 | |
| May-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite